Patent · US Active

Compositions and methods of enhancing immune responses to enteric pathogens

US10716840B2 · kind B2 · utility

1Cited by
38References
19Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 5, 2019
Grant dateJul 21, 2020
Priority date
Expiry dateAug 5, 2039

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Vaccine vectors capable of eliciting an immune response to enteric bacteria and methods of using the same are provided. The vaccine vectors include a polynucleotide encoding a PAL polypeptide. The PAL polypeptide may be expressed on the surface of the vaccine vector. The vaccine vector may also include a second polypeptide encoding an immunostimulatory polypeptide such as a CD154 polypeptide or an HMGB1 polypeptide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.